923023-08-9 Usage
Uses
Used in Pharmaceutical Industry:
Trans-4-methylamino-cyclohexanol hydrochloride is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of local anesthetics and other medicinal compounds. Its unique chemical structure allows it to be a crucial component in the formulation of drugs that require specific properties for effective delivery and action within the body.
Used in Synthesis of Local Anesthetics:
In the field of anesthesiology, trans-4-methylamino-cyclohexanol hydrochloride is utilized as a precursor in the production of local anesthetics. Its role in the synthesis process is vital for creating compounds that can effectively block nerve conduction, providing temporary pain relief during medical procedures.
Used in Drug Formulation:
Due to its solubility and chemical properties, trans-4-methylamino-cyclohexanol hydrochloride is also used in the formulation of various drugs. It aids in enhancing the solubility and stability of the final drug product, ensuring optimal performance and bioavailability when administered to patients.
It is important to handle trans-4-methylamino-cyclohexanol hydrochloride with care, as it can cause irritation and harm if not properly managed, highlighting the need for safe storage and handling protocols in pharmaceutical manufacturing processes.
Check Digit Verification of cas no
The CAS Registry Mumber 923023-08-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,3,0,2 and 3 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 923023-08:
(8*9)+(7*2)+(6*3)+(5*0)+(4*2)+(3*3)+(2*0)+(1*8)=129
129 % 10 = 9
So 923023-08-9 is a valid CAS Registry Number.
923023-08-9Relevant academic research and scientific papers
CYCLOHEXYLAMIN ISOQUINOLONE DERIVATIVES AS RHO-KINASE INHIBITORS
-
Page/Page column 88-89, (2010/11/25)
The invention relates to 6-cyclohexylamine-substituted isoquinolone derivatives of the formula (I) or isoquinoline derivatives of the formula (I’) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.
